$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000093454923000031 Filed on March 17, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$14.80M	$13.12M	$59.22M
YoY Change	9.6%	-79.26%	393.36%
Cost Of Revenue	$9.958M	$9.611M	$37.39M
YoY Change	11.31%	21.26%	327.34%
Gross Profit	$4.845M	$3.510M	$21.84M
YoY Change	6.23%	-93.66%	-72.46%
Gross Profit Margin	32.73%	26.75%	36.87%
Selling, General & Admin	$13.95M	$18.06M	$61.30M
YoY Change	6.76%	-12.03%	64.77%
% of Gross Profit	287.99%	514.5%	280.75%
Research & Development	$216.0K		$626.0K
YoY Change	13.68%		213.0%
% of Gross Profit	4.46%		2.87%
Depreciation & Amortization	$3.381M	$3.374M	$13.51M
YoY Change	0.36%	-68.43%	26.44%
% of Gross Profit	69.78%	96.13%	61.89%
Operating Expenses	$14.17M	$18.06M	$61.93M
YoY Change	6.86%	-23.01%	65.56%
Operating Profit	-$9.324M	-$14.55M	-$40.09M
YoY Change	9.59%	-145.64%	-375.64%
Interest Expense	$21.25M	-$5.842M	-$87.06M
YoY Change	-126.69%	-102.96%	-154.37%
% of Operating Profit
Other Income/Expense, Net	$21.25M		-$87.06M
YoY Change	-126.69%		-154.37%
Pretax Income	$11.93M	-$20.39M	-$127.2M
YoY Change	-113.53%	-108.92%	-172.8%
Income Tax	$2.483M	-$1.812M	-$16.21M
% Of Pretax Income	20.81%
Net Earnings	$9.447M	-$20.53M	-$125.1M
YoY Change	-112.89%	-110.03%	-183.83%
Net Earnings / Revenue	63.82%	-156.45%	-211.18%
Basic Earnings Per Share	$0.12		-$3.13
Diluted Earnings Per Share	-$0.07	-$0.50	-$3.13
COMMON SHARES
Basic Shares Outstanding	58.57M shares	43.54M shares	42.46M shares
Diluted Shares Outstanding	89.07M shares		42.46M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$461.7M	$386.1M	$386.1M
YoY Change	-19.37%	-45.42%	-45.42%
Cash & Equivalents	$364.2M	$287.8M	$287.8M
Short-Term Investments	$97.47M	$98.36M	$98.36M
Other Short-Term Assets	$20.10M	$19.39M	$19.39M
YoY Change	305.14%	306.97%	306.97%
Inventory	$14.73M	$14.22M	$14.22M
Prepaid Expenses
Receivables	$8.666M	$8.231M	$8.231M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$505.2M	$428.0M	$428.0M
YoY Change	-15.34%	-41.43%	-41.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.275M	$3.537M	$5.542M
YoY Change	-15.7%	-15.44%	-10.76%
Goodwill	$7.541M	$7.541M
YoY Change	0.95%	0.95%
Intangibles	$33.62M	$36.66M
YoY Change	-26.52%	-24.87%
Long-Term Investments	$30.93M	$30.93M
YoY Change	0.0%	0.0%
Other Assets	$5.359M	$5.202M	$5.202M
YoY Change	1.63%	-1.53%	-8.75%
Total Long-Term Assets	$51.41M	$54.94M	$54.94M
YoY Change	-20.56%	-19.41%	-19.41%
TOTAL ASSETS
Total Short-Term Assets	$505.2M	$428.0M	$428.0M
Total Long-Term Assets	$51.41M	$54.94M	$54.94M
Total Assets	$556.6M	$482.9M	$482.9M
YoY Change	-15.85%	-39.55%	-39.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.413M	$6.036M	$6.036M
YoY Change	58.8%	10.96%	10.96%
Accrued Expenses	$15.69M	$18.80M	$18.80M
YoY Change	-3.17%	99.54%	99.54%
Deferred Revenue	$1.206M	$1.229M
YoY Change	-17.0%	10.32%
Short-Term Debt	$61.35M	$60.45M	$60.45M
YoY Change	-63.63%	-66.65%	-66.65%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$90.21M	$87.21M	$87.21M
YoY Change	-53.6%	-56.44%	-56.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.674M	$1.675M	$105.7M
YoY Change	43.69%	-72.81%	-21.61%
Total Long-Term Liabilities	$1.674M	$1.675M	$105.7M
YoY Change	43.69%	-72.81%	-21.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$90.21M	$87.21M	$87.21M
Total Long-Term Liabilities	$1.674M	$1.675M	$105.7M
Total Liabilities	$179.4M	$193.7M	$204.7M
YoY Change	-40.2%	-45.23%	-43.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$297.3M	-$306.8M
YoY Change	16.61%	68.82%
Common Stock	$58.00K	$43.00K
YoY Change	23.4%	-12.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$98.26M	$98.26M
YoY Change	68.63%	107.82%
Treasury Stock Shares		16.18M shares
Shareholders Equity	$344.6M	$258.3M	$278.2M
YoY Change
Total Liabilities & Shareholders Equity	$556.6M	$482.9M	$482.9M
YoY Change	-15.85%	-39.55%	-39.55%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$9.447M	-$20.53M	-$125.1M
YoY Change	-112.89%	-110.03%	-183.83%
Depreciation, Depletion And Amortization	$3.381M	$3.374M	$13.51M
YoY Change	0.36%	-68.43%	26.44%
Cash From Operating Activities	-$4.349M	-$23.74M	-$37.34M
YoY Change	37.5%	-213.43%	-380.17%
INVESTING ACTIVITIES
Capital Expenditures	$83.00K	$180.0K	$732.0K
YoY Change	144.12%	-102.24%	704.4%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$2.866M	$60.39M	$190.2M
YoY Change	-71.24%	28.51%	234.6%
Cash From Investing Activities	$2.783M	$60.21M	$184.5M
YoY Change	-71.98%	54.51%	415.97%
FINANCING ACTIVITIES
Cash Dividend Paid	$700.0K		$2.799M
YoY Change	0.0%		92.77%
Common Stock Issuance & Retirement, Net			$50.99M
YoY Change			1170.89%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$78.00M	8.470M	-$166.1M
YoY Change	-391.46%	-281.02%	-378.11%
NET CHANGE
Cash From Operating Activities	-$4.349M	-23.74M	-$37.34M
Cash From Investing Activities	$2.783M	60.21M	$184.5M
Cash From Financing Activities	$78.00M	8.470M	-$166.1M
Net Change In Cash	$76.44M	44.94M	-$21.58M
YoY Change	-482.36%	-18.61%	-119.83%
FREE CASH FLOW
Cash From Operating Activities	-$4.349M	-$23.74M	-$37.34M
Capital Expenditures	$83.00K	$180.0K	$732.0K
Free Cash Flow	-$4.432M	-$23.92M	-$38.07M
YoY Change	38.63%	-182.61%	-387.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Registrant Name EntityRegistrantName	ACACIA RESEARCH CORP
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	200589000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58569131	shares
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287786000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	61608000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2022Q4	actg	Equity Method Investments Current EquityMethodInvestmentsCurrent	30934000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8231000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14222000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19388000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	427985000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	0	usd
CY2021Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	418000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4183000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	7541000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	36658000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2005000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5202000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5283000	usd
CY2022Q4	us-gaap	Assets Assets	482928000	usd
CY2021Q4	us-gaap	Assets Assets	798856000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6036000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5440000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	14058000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6227000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4737000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3698000	usd
CY2022Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	699000	usd
CY2021Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	2463000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1229000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1114000	usd
CY2022Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	60450000	usd
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	181248000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87209000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	200190000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	568000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	581000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	11291000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	16835000	usd
CY2022Q4	actg	Embedded Derivative Fair Value Of Embedded Derivative Liability1 EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1	84780000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1873000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	742000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1675000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6161000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	193682000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	353628000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	19924000	usd
CY2021Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	14753000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43484867	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43484867	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48807748	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48807748	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	49000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	16183703	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5388469	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	98258000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	47281000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	663284000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	648389000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-306789000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181724000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	258280000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	419433000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	11042000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	11042000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	269322000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	482928000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	798856000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59223000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88047000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	626000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	200000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1538000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-40092000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2752000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3591000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	13102000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-40408000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3324000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-89000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	6432000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	7922000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5442000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	501000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-87058000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	160107000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-127150000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	174652000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16211000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24287000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-110939000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	150365000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14126000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1168000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-125065000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	149197000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-133035000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	118804000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42460504	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48797290	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.13
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.43
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-133035000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	188224000	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	42460504	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	98470870	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.13
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.91
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-110939000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	14126000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	5171000	usd
CY2022	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	2799000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	116000	usd
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	55000	usd
CY2022	actg	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	20650000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1600000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3820000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	50988000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	288316000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	150365000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1168000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	3829000	usd
CY2021	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	1452000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	202000	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4012000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-110939000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	150365000	usd
CY2022	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	0	usd
CY2021	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-2752000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3591000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13514000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10688000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	90000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	110000	usd
CY2022	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	1613000	usd
CY2021	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	8280000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1895000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-4651000	usd
CY2022	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	11598000	usd
CY2021	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	-44037000	usd
CY2022	actg	Loss From Warrant Exercises LossFromWarrantExercises	-2004000	usd
CY2021	actg	Loss From Warrant Exercises LossFromWarrantExercises	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3820000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2053000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-3324000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-89000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-263695000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	87527000	usd
CY2022	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	125318000	usd
CY2021	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	116129000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	42531000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	3530000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-17810000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	15742000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-998000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	747000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5291000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1906000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5986000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	78000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-136000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	760000	usd
CY2022	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-1764000	usd
CY2021	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	301000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	100000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-246000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37336000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13326000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	33250000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5000000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21000000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	3591000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	112142000	usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	66624000	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	273934000	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	154784000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	4021000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	28404000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2362000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	732000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	91000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	184464000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35751000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50988000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4012000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	115000000	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	120000000	usd
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	50000000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	2799000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	1452000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1600000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9250000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	202000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-166137000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	59738000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2566000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21575000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	108815000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309361000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	200546000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	287786000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309361000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest	7229000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest	7336000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	384000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25000	usd
CY2022	actg	Patent Acquisition In Exchange Of Notes Receivable PatentAcquisitionInExchangeOfNotesReceivable	0	usd
CY2021	actg	Patent Acquisition In Exchange Of Notes Receivable PatentAcquisitionInExchangeOfNotesReceivable	4000000	usd
CY2022	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	9000000	usd
CY2021	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	5000000	usd
CY2022	actg	Distribution To Noncontrolling Interests In Subsidiaries DistributionToNoncontrollingInterestsInSubsidiaries	14126000	usd
CY2021	actg	Distribution To Noncontrolling Interests In Subsidiaries DistributionToNoncontrollingInterestsInSubsidiaries	1168000	usd
CY2022	actg	Number Of Patent Portfolios Acquired NumberOfPatentPortfoliosAcquired	0	patent
CY2022Q1	actg	Number Of Patent Portfolios Acquired NumberOfPatentPortfoliosAcquired	1	patent
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported consolidated results of operations or cash flows.</span></div>
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, estimates of variable consideration for revenue, including sales returns, the valuation of equity securities without readily determinable fair value, the determination of excess and obsolete inventories, bad debt allowances and product warranty liabilities, the valuation of Series A redeemable convertible preferred stock (the “Series A Redeemable Convertible Preferred Stock”), embedded derivatives, Series A warrants (the “Series A Warrants”) and Series B warrants (the “Series B Warrants”), stock-based compensation expense, impairment of goodwill, patent-related and other intangible assets, the determination of the economic useful life of amortizable intangible assets, and income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</span></div>
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	131000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	222000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	681000	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	772000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	222000	usd
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	260000	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	25000	usd
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	17000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk are cash equivalents and accounts receivable. The Company places its cash equivalents primarily in highly rated money market funds, investments in U.S. treasury securities and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. The Company has not experienced any significant losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three licensees individually accounted for 15%, 15% and 27% of revenues recognized during the year ended December 31, 2022. Two licensees individually accounted for 66% and 16% of revenues recognized during the year ended December 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, ARG has not had material foreign operations. Based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable license revenue arrangement, for the years ended December 31, 2022 and 2021, 3% and 69%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. Refer to Note 17 for additional information regarding revenue from customers by geographic region.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two licensees individually represented approximately 57% and 43% of accounts receivable at December 31, 2022. Two licensees individually represented approximately 59% and 41% of accounts receivable at December 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industrial Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Printronix customer accounted for more than 10% of revenue for the years ended December 31, 2022 and 2021. Printronix has significant foreign operations, refer to Note 17 for additional information regarding net sales to customers by geographic region.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two Printronix customers individually accounted for 15% and 11% of accounts receivable as of December 31, 2022, and one customer represented 11% of accounts receivable as of December 31, 2021. Exposure to credit risk is limited by the large number of customers comprising the remainder of the Printronix customer base and by periodic customer credit evaluations performed by Printronix.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Printronix vendor accounted for 10% or more of purchases for the years ended December 31, 2022 and 2021. Accounts payable to two vendors represented 21% and 13% of accounts payable as of December 31, 2022, and one vendor represented 14% of accounts payable as of December 31, 2021.</span></div>
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	2950000	gbp
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	4000000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	291000	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	69000	usd
CY2022	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	Embedded DerivativesEmbedded derivatives that are required to be bifurcated from their host contract are valued separately from the host instrument.
CY2022	us-gaap	Advertising Expense AdvertisingExpense	315000	usd
CY2021Q4	us-gaap	Advertising Expense AdvertisingExpense	52000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	63383000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	14819000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	16594000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	61608000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	99859000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	264879000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	2960000	usd
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	361778000	usd
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	102067000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4335000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3207000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3045000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1712000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7340000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4011000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	14720000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	8930000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	498000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14222000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8930000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5327000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4761000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1790000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	578000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3537000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4183000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	1400000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	438000	usd
CY2020Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7470000	usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7470000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	7541000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7470000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343533000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	306875000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	36658000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343533000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	294740000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	48793000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12100000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10300000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	usd
CY2022	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	usd
CY2022	actg	Finite Lived Intangible Assets Write Offs FiniteLivedIntangibleAssetsWriteOffs	35000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12068000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10693000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8347000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2483000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1733000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1334000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	36658000	usd
CY2022Q4	actg	Accrued Patent Investment Costs AccruedPatentInvestmentCosts	15000000	usd
CY2022Q4	actg	Accrued Patent Investment Costs Paid AccruedPatentInvestmentCostsPaid	6000000	usd
CY2022Q4	actg	Accrued Patent Investment Costs Current AccruedPatentInvestmentCostsCurrent	9000000	usd
CY2022	actg	Accrued Patent Investment Costs Current Installment Amount AccruedPatentInvestmentCostsCurrentInstallmentAmount	3000000	usd
CY2022Q4	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	1173000	usd
CY2021Q4	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	438000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	0	usd
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	3000000	usd
CY2021Q4	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	usd
CY2021Q4	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	usd
CY2022Q4	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2022Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9300000	usd
CY2022	actg	Loss From Warrant Exercises LossFromWarrantExercises	-2000000	usd
CY2022Q4	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2022Q4	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2022	us-gaap	Legal Fees LegalFees	46000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	408000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1500000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	851000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1539000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1137000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	453000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	238000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	65000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3432000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1559000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1873000	usd
	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	1200000	usd
CY2022Q4	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	4800000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	3125819	shares
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	40000000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2022	actg	Ownership Percent Of Voting Stock OwnershipPercentOfVotingStock	0.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1155000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	535000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1155000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	235000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	18000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4700000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y10M24D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P5Y
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	173000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
	actg	Defined Contribution Plan Employer Matching Contribution Per Cent Addition Of Employees Gross Pay DefinedContributionPlanEmployerMatchingContributionPerCentAdditionOfEmployeesGrossPay	0.50	usd
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.01
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	3200000	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	473000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-126810000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	175635000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-340000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-983000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-127150000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	174652000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.05
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.06
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.04
CY2022	actg	Effective Income Tax Rate Reconciliation Derivative Fair Value Adjustment Percent EffectiveIncomeTaxRateReconciliationDerivativeFairValueAdjustmentPercent	-0.02
CY2021	actg	Effective Income Tax Rate Reconciliation Derivative Fair Value Adjustment Percent EffectiveIncomeTaxRateReconciliationDerivativeFairValueAdjustmentPercent	0.05
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.07
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.01
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.01
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.13
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.14
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-54000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-482000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-15000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-606000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-8530000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-1142000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-8545000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	24789000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-54165000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	259000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1573000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-28000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	332000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	25020000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-52260000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-7667000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16211000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24287000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	36518000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	47386000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	78428000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	35000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	607000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	383000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	18000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	1551000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	1495000	usd
CY2022Q4	actg	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	784000	usd
CY2021Q4	actg	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	726000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	94000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	50457000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81050000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48250000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40585000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2207000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	40465000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	782000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	726000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2166000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2572000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	55696000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	23000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2948000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	59017000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	742000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	18552000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48300000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40600000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7700000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-36400000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	31200000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42460504	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48797290	shares
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	887000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	731000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	27000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	129000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	127000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	760000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	887000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	760000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	887000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	887000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	760000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-125065000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	149197000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2799000	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1452000	usd
CY2022	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	5171000	usd
CY2021	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	3829000	usd
CY2022	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	0	usd
CY2021	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	25112000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-133035000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	118804000	usd
CY2022	actg	Dividend On Series A Redeemable Convertible Preferred Stock DividendOnSeriesARedeemableConvertiblePreferredStock	0	usd
CY2021	actg	Dividend On Series A Redeemable Convertible Preferred Stock DividendOnSeriesARedeemableConvertiblePreferredStock	1452000	usd
CY2022	actg	Accretion Of Series A Redeemable Convertible Preferred Stock AccretionOfSeriesARedeemableConvertiblePreferredStock	0	usd
CY2021	actg	Accretion Of Series A Redeemable Convertible Preferred Stock AccretionOfSeriesARedeemableConvertiblePreferredStock	3829000	usd
CY2022	actg	Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative	0	usd
CY2021	actg	Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative	8280000	usd
CY2022	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	0	usd
CY2021	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	0	usd
CY2022	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	0	usd
CY2021	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	-44037000	usd
CY2022	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	0	usd
CY2021	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	4658000	usd
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	25112000	usd
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	1388000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-133035000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	188224000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42460504	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98470870	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.13
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.43
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.13
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.91
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	102558720	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5393750	shares
CY2022Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59223000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88047000	usd
CY2022	us-gaap	Royalty Expense RoyaltyExpense	1212000	usd
CY2021	us-gaap	Royalty Expense RoyaltyExpense	1142000	usd
CY2022	actg	Contingent Legal Fees ContingentLegalFees	2444000	usd
CY2021	actg	Contingent Legal Fees ContingentLegalFees	12074000	usd
CY2022	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	3970000	usd
CY2021	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	5462000	usd
CY2022	actg	Amortization Of Patents AmortizationOfPatents	10403000	usd
CY2021	actg	Amortization Of Patents AmortizationOfPatents	9851000	usd
CY2022	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	19359000	usd
CY2021	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	7407000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	37388000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	36098000	usd
CY2022	us-gaap	Gross Profit GrossProfit	21835000	usd
CY2021	us-gaap	Gross Profit GrossProfit	51949000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-40092000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	14545000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-87058000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	160107000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-127150000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	174652000	usd
CY2022Q4	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	61608000	usd
CY2021Q4	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	361778000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	30934000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	30934000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	98358000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	398528000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	156394000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	172726000	usd
CY2022Q4	us-gaap	Assets Assets	482928000	usd
CY2021Q4	us-gaap	Assets Assets	798856000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59223000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88047000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	3537000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4183000	usd

Files In Submission

Name	View Source	Status
0000934549-23-000031-index-headers.html	Edgar Link	pending
0000934549-23-000031-index.html	Edgar Link	pending
0000934549-23-000031.txt	Edgar Link	pending
0000934549-23-000031-xbrl.zip	Edgar Link	pending
a1017golbyseparationagmt_a.htm	Edgar Link	pending
a1018acaciaconsultingagree.htm	Edgar Link	pending
actg-20221231.htm	Edgar Link	pending
actg-20221231.xsd	Edgar Link	pending
actg-20221231xex211.htm	Edgar Link	pending
actg-20221231xex231.htm	Edgar Link	pending
actg-20221231xex232.htm	Edgar Link	pending
actg-20221231xex311.htm	Edgar Link	pending
actg-20221231xex312.htm	Edgar Link	pending
actg-20221231xex321.htm	Edgar Link	pending
actg-20221231xex322.htm	Edgar Link	pending
actg-20221231_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
actg-20221231_cal.xml	Edgar Link	unprocessable
actg-20221231_def.xml	Edgar Link	unprocessable
actg-20221231_pre.xml	Edgar Link	unprocessable
actg-20221231_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
actg-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2023 Q1 Form 10-K Financial Statement

#000093454923000031 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2023 Q1 Form 10-K Financial Statement

#000093454923000031 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg